SEI Investments’s Assembly Biosciences ASMB Stock Holding History

SEI Investments’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,745	Closed	-$604K	–	3242
2025 Q4	$604K	Buy	+17,745	New	+$572K	﹤0.01%	2426
2021 Q3	–	Sell	-2,718	Closed	-$120K	–	2553
2021 Q2	$120K	Sell	2,718 -1,169	-30%	-$57.9K	﹤0.01%	2503
2021 Q1	$215K	Hold	3,887	–	–	﹤0.01%	2366
2020 Q4	$282K	Buy	+3,887	New	+$456K	﹤0.01%	2233

Other funds holding ASMB

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

SEI Investments's ASMB Position: Q1 2026 in Review

SEI Investments sold out of Assembly Biosciences (ASMB) in Q1 2026, closing a stake of 17,745 shares — an estimated $604K sold.

SEI Investments first reported a position in ASMB in Q4 2020 and held it in 4 quarters. The position peaked at $604K in Q4 2025. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

SEI Investments reported no remaining Assembly Biosciences position as of Q1 2026 after selling out during the quarter.
SEI Investments sold 17,745 Assembly Biosciences shares in Q1 2026, an estimated $604K.
SEI Investments first reported a position in Assembly Biosciences in Q4 2020 and held it in 4 quarters.
SEI Investments's Assembly Biosciences position peaked at $604K in Q4 2025.
75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.